Combining Enzalutamide with Radium-223 Significantly Improves rPFS as First-Line Therapy for Patients with mCRPC By Ogkologos - August 27, 2025 430 0 Facebook Twitter Google+ Pinterest WhatsApp Findings from the PEACE-3 study Source RELATED ARTICLESMORE FROM AUTHOR Lisocabtagene Maraleucel Shows Deep, Durable Responses in Patients with Relapsed or Refractory MZL After at Least Two Previous Lines of Systemic Therapy FDA Updates Safety Labelling for Capecitabine and 5-FU on Risks Associated with DPD Deficiency Ultra-Low-Dose Nivolumab Significantly Improves OS Over Chemotherapy in Pretreated Patients with Solid Tumours MOST POPULAR No Improvement in OS or PFS from Sacituzumab Govitecan Compared with... March 24, 2025 Aiming to Prevent Cancer Cases, ESMO Calls Against Misleading Alcohol-Labelling Following... December 3, 2025 Women in science: Cancer research pioneers – part 1 January 18, 2023 Foodie Fridays: Watermelon Salad August 27, 2021 Load more HOT NEWS CVS, Walgreens, Rite Aid Suspend Sales Of Zantac Following Cancer-Causing Concerns 7 ways we’ve influenced progress in lung cancer Pembrolizumab Provides First-Ever Overall Survival Improvement in Kidney Cancer Off Target: Investigating the Abscopal Effect as a Treatment for Cancer
